Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive

Abstract

We previously identified on chromosome 6 an interval of 51 kb as the most likely interval in the HLA region for a disease-susceptibility locus for multiple sclerosis (MS). The interval was located between markers G511525 and D6S1666 and identified by the haplotype sharing statistic (HSS). The study comprised 124 patients with ancestry within the northeastern part of the Netherlands. Haplotype clustering indicated that two different ancestral haplotypes likely include a polymorphism involved in susceptibility to MS. To investigate the dominance characteristics of the MS susceptibility locus in the HLA class II region, we reanalyzed our data, performing genotype association analyses for both marker loci separately and for the two-locus haplotype. The two-locus genotype association analysis showed that in individuals who carry only one of the risk haplotypes the risk for MS is moderately increased (odds ratio (OR) 2.82; 95% confidence interval (CI) 1.50–5.31). However, in individuals carrying two risk haplotypes the risk for MS is highly increased compared with individuals who carry no risk haplotypes (OR 37.00; 95% CI 8.31–164.74). This susceptibility locus for MS seems to follow an intermediate mode of inheritance. Fitting additive, multiplicative and third power risk models to the data, the effect appears to be significantly stronger than additive.

This is a preview of subscription content, log in to check access.

References

  1. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U (1994) Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39:41–48

  2. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710–716

  3. Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, De Keyser J, Zwanikken CP, Hulsbeek M, Hofstra RM, Buys CH, te Meerman GJ (2001) Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 3:221–230

  4. Clerget-Darpoux F, Govaerts A, Feingold N (1984) HLA and susceptibility to multiple sclerosis. Tissue Antigens 24:160–169

  5. Eoli M, Pandolfo M, Amoroso A, Salmaggi A, Zaffaroni M, Gasparini P, DiDonato S, Milanese C, Zeviani M (1995) Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur J Hum Genet 3:303–311

  6. Epplen C, Jackel S, Santos EJ, D’Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rude KP, Weber F, Stover J, Poser S, Gehler W, Malin JP, Przuntek H, Epplen JT (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341–352

  7. Fogdell A, Olerup O, Fredrikson S, Vrethem M, Hillert J (1997) Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology 48:758–762

  8. Haile RW, Iselius L, Hodge SE, Morton NE, Detels R (1981) Segregation and linkage analysis of 40 multiplex multiple sclerosis families. Hum Hered 31:252–258

  9. Haines JL, Ter Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Oksenberg JR (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 13:469–471

  10. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 7:1229–1234

  11. Hauser SL, Fleischnick E, Weiner HL, Marcus D, Awdeh Z, Yunis EJ, Alper CA (1989) Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 39:275–277

  12. Ho HZ, Tiwari JL, Haile RW, Terasaki PI, Morton NE (1982) HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics 15:509–517

  13. Jersild C, Svejgaard A, Fog T (1972) HL-A antigens and multiple sclerosis. Lancet 1:1240–1241

  14. de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG (2002) Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59:549–555

  15. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA (1995) Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 58:183–190

  16. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998) DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7:1235–1237

  17. Naito S, Namerow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens 2:1–4

  18. Nolte IM, Spijker GT, Boon M, Jansen RC, Postma DS, Buys CHCM, Te Meerman GJ (2002) Haplotype sharing statistics: fine-mapping by comparing patients and controls for the length of haplotype sharing. PhD Thesis (I.M. Nolte), University of Groningen

  19. Olerup O, Hillert J (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1–15

  20. Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Koch-Henriksen N, Sawcer S, Fugger L, Sorensen PS, Svejgaard A (1999) Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 46:612–616

  21. Payami H, Louis EJ, Klitz W, Lo SK, Thomson G (1986) Family and population analysis of multiple sclerosis. Genet Epidemiol 1(Suppl):381–386

  22. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

  23. Rasmussen HB, Kelly MA, Clausen J (2001) Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult Scler 7:91–93

  24. Risch N (1986) Conditional linkage analysis of multiple sclerosis data. Genet Epidemiol 1(Suppl):387–392

  25. Sadovnick AD, Spence MA, Tideman S (1981) A goodness-of-fit test for the polygenic threshold model: application to multiple sclerosis. Am J Med Genet 8:355–361

  26. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464–468

  27. Sherman SL, Haile RW, MacLean CJ, Yee S (1986) Combined segregation and linkage analysis of multiple sclerosis. Genet Epidemiol 1(Suppl):393–398

  28. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516

  29. Stewart GJ, McLeod JG, Basten A, Bashir HV (1981) HLA family studies and multiple sclerosis: a common gene, dominantly expressed. Hum Immunol 3:13–29

  30. Thomson G (1983) Investigation of the mode of inheritance of the HLA associated diseases by the method of antigen genotype frequencies among diseased individuals. Tissue Antigens 21:81–104

  31. Tienari PJ, Terwilliger JD, Ott J, Palo J, Peltonen L (1994) Two-locus linkage analysis in multiple sclerosis (MS). Genomics 19:320–325

  32. Tiwari JL, Hodge SE, Terasaki PI, Spence MA (1980) HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet 32:103–111

  33. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998) Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51:742–747

Download references

Acknowledgements

The authors thank G. van der Steege for molecular biological assistance.

Author information

Correspondence to Maartje Boon.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Boon, M., Nolte, I.M., De Keyser, J. et al. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive. Hum Genet 115, 280–284 (2004). https://doi.org/10.1007/s00439-004-1169-8

Download citation

Keywords

  • Multiple Sclerosis
  • Risk Allele
  • Marker Locus
  • Risk Haplotype
  • Ancestral Haplotype